Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Gossamer Bio, Inc. (NASDAQ: GOSS)
GOSS Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
145.30%
Analyst Rating:
BUY
Analyst Forecast (1yr):
400%
GOSS Stock Analysis
GOSS
PE Ratio:
GOSS
PEG Ratio:
Not Available
GOSS
Forward EPS Growth (12 month):
0.00%
GOSS
PS Ratio:
0.8
GOSS
PSG Ratio:
GOSS
Forward Revenue Growth (12 month):
155.20%
GOSS Articles
No data was found